Characterisation of an Isogenic Model of Cisplatin Resistance in Oesophageal Adenocarcinoma Cells

Cisplatin (cis-diamminedichloroplatinum) is widely used for the treatment of solid malignancies; however, the development of chemoresistance hinders the success of this chemotherapeutic in the clinic. This study provides novel insights into the molecular and phenotypic changes in an isogenic oesopha...

Descripción completa

Detalles Bibliográficos
Autores principales: Buckley, Amy M., Bibby, Becky AS., Dunne, Margaret R., Kennedy, Susan A., Davern, Maria B., Kennedy, Breandán N., Maher, Stephen G., O’Sullivan, Jacintha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6469161/
https://www.ncbi.nlm.nih.gov/pubmed/30791601
http://dx.doi.org/10.3390/ph12010033

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6469161/
https://www.ncbi.nlm.nih.gov/pubmed/30791601
http://dx.doi.org/10.3390/ph12010033

Ejemplares similares